Toggle navigation
Menu
Home
News
Local
National
World
Politics
Sports
Entertainment
Business
Health
News Tip Hotline
Weather
Bend
Traffic
Live Traffic Cams
Central Oregon
Mountain Passes
Road Reports
Trip Check
Gas Prices
Closures and Delays
Stations
KQAK-FM 105.7
The Peak 104.1
The Ranch 95.7 FM
KBNW-AM/FM
KRCO-AM
Events
Upcoming
Concerts
Submit An Event
Submit A PSA
Interviews
Inside Central Oregon
Central Oregon Spotlight
Water Wise Tips
HBG Interviews
Ray’s Random Questions
Just Used Cars as Heard on KQAK & The Ranch
About MCO
Contact/About Us
Advertise
Careers
Media Kit
Radio Stations
Contest Rules
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Profound Medical Corp
(TSX:
PRN
)
8.800
-0.180 (-2.00%)
Delayed Quote
Updated: 10:12 AM EDT, Oct 16, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Profound Medical Corp
< Previous
1
2
3
4
Next >
TULSA Abstracts at the 15th Interventional MRI Symposium Strengthen Real-World Evidence, Clinical Differentiation, and Platform Expansion Opportunity
October 14, 2026
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical and Telix Pharmaceuticals Enter Co-Education Agreement to Advance PSMA-Informed Prostate Care
October 09, 2026
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Reports Strong Preliminary Third Quarter 2026 Revenue
October 07, 2026
Anticipates Q3-2026 revenue of $9.8 million to $10.0 million, exceeding Bloomberg analyst consensus by approximately 45% to 47%
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical to Participate in Lake Street’s 10th Annual Best Ideas Growth Conference
September 03, 2026
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Further Strengthens Executive Leadership Team with Appointment of Richard Fabian as President
September 01, 2026
From
Profound Medical Corp.
Via
GlobeNewswire
Profound’s Introduction of New Real-time Interventional MRI Software Paving the Way for Full ‘TULSA Days’
August 17, 2026
Most recent TDC software provides a potential roadmap for customers to easily achieve up to 6 TULSA Procedures™ per system per day
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Announces Management Change
August 14, 2026
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Launches ‘Let's Huddle’, a Global Community Supporting Men Throughout Their Prostate Care Journey
August 13, 2026
A patient-centered initiative focused on education, connection, and support
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Reports Second Quarter 2026 Financial Results
August 06, 2026
From
Profound Medical Corp.
Via
GlobeNewswire
Robotic Radical Prostatectomy Comes Up ‘Short’ in CAPTAIN Trial
July 24, 2026
– Whole-gland TULSA ablation demonstrates statistically significant superior penile length preservation compared to robotic RP at 1 month –
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical to Release Second Quarter 2026 Financial Results on August 6th – Conference Call to Follow
July 16, 2026
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical: Autonomous Robotics and Incisionless Surgery to Have Exceptional Presence at SRS2026
July 15, 2026
From
Profound Medical Corp.
Via
GlobeNewswire
Telix Announces Collaborations to Explore PSMA-PET Imaging in Emerging Prostate Cancer Treatment Approaches
May 15, 2026
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Profound to Showcase TULSA-PRO®, the TULSA Procedure™ and the Future of iMRI at AUA2026
May 14, 2026
Company to explore the potential of integrating TULSA-PRO with PSMA PET molecular imaging technologies to enhance ablation planning and monitoring
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Reports Strong First Quarter 2026 Financial Results
May 07, 2026
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical to Release First Quarter 2026 Financial Results on May 7 – Conference Call to Follow
April 16, 2026
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical to Participate in the 2026 Bloom Burton & Co. Healthcare Investor Conference
April 14, 2026
From
Profound Medical Corp.
Via
GlobeNewswire
Incision-Free, MRI-Guided Prostate Treatment with Profound’s TULSA-PRO® to be Featured in Multiple Presentations at the Upcoming 2026 Society of Interventional Radiology Scientific Meeting
April 01, 2026
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Congratulates Texas Prostate on Achieving 100th TULSA Procedure™ Milestone
March 27, 2026
From
Profound Medical Corp.
Via
GlobeNewswire
CAPTAIN Trial Comparing Profound’s MRI-Guided TULSA Procedure™ to Robotic Radical Prostatectomy Successfully Meets Primary Safety Endpoint, Preservation of Erectile Function and Urinary Continence
March 13, 2026
From
Profound Medical Corp.
Via
GlobeNewswire
Upcoming Meeting Dates - March 23, 2026
March 23, 2026
Toronto, Ontario--(Newsfile Corp. - March 23, 2026) - The following is a list of Upcoming Meeting Dates announced this week...
Via
Newsfile
Profound Medical to Host Investor Call to Discuss First Clinical Outcomes from the CAPTAIN Trial on March 13; Participate in ROTH Investor Conference on March 22-24
March 09, 2026
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Reports Fourth Quarter and Full Year 2025 Financial Results
March 05, 2026
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical to Release Fourth Quarter and Full Year 2025 Financial Results on March 5th – Conference Call to Follow
February 12, 2026
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Honored with INOVAIT’s 2025–2026 Mount Logan Award Recognizing the TULSA Procedure™ for Prostate Disease
February 12, 2026
From
Profound Medical Corp.
Via
GlobeNewswire
PRO FAMILIA and Profound Medical Celebrate 500 Sonalleve® Procedures, Expanding Access to Incision-Free Care for Women’s Health
February 05, 2026
Milestone reflects accelerating adoption of innovative, non-surgical treatment options for uterine conditions
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Announces Upcoming Investor Events
January 27, 2026
From
Profound Medical Corp.
Via
GlobeNewswire
Mount Sinai Becomes First in Metro New York to Deliver Incision-Free, MRI-Guided Prostate Treatment with TULSA-PRO®
January 15, 2026
From
Profound Medical Corp.
Via
GlobeNewswire
Johns Hopkins Medicine Treats First Commercial TULSA-PRO® Case
January 06, 2026
Profound Medical marks major milestone as the hospital launches its state-of-the-art iMRI suite to expand access to advanced prostate care
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Surpasses 2025 TULSA-PRO® Installed Base Goal
January 12, 2026
Company’s year-end TULSA-PRO installed base stood at 78 systems; qualified sales pipeline grew to 97 new systems
From
Profound Medical Corp.
Via
GlobeNewswire
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
581446795
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/60.0.3112.113 Safari/537.36
00fbf3724072e3a4c643b60a8db5a8756c4f8c05
1
